Yes, that's absolutely right. That's what C-TAP and the MPP are.
The problem for COVAX is that it has to compete with yet another player in this war of vaccine nationalism dominated by a fend-for-yourself mentality. COVAX hasn't been able to compete in a marketplace where the wealthiest countries can afford to pay a lot more for vaccine doses. COVAX is really struggling to procure supply.
Nonetheless, it was a promising initiative, and Canada's involvement was a good thing. If, however, Canada once again secures 500% of its vaccine dose requirements elsewhere, thereby competing with COVAX, it will no longer be part of the initiative. We are helping to stop COVAX in its tracks.